Isolation of more potent oncolytic paramyxovirus by bioselection

Rudolf Beier(Bayer (Germany)), Dominik Mumberg(Bayer (Germany))
Gene Therapy
February 23, 2012
10.1038/gt.2012.13
Cited by 12

Related Papers

Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
|Clinical Cancer Research|2019|121
Supplementary Methods from Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
|Unknown|2023|0
Supplementary Methods from Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer
|Unknown|2023|0